 | • レポートコード：20QY06-05528 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、抗体薬物複合体のグローバル市場について種類別（アドセトリス（Adcetris）、カドサイラ（Kadcyla））、用途別（乳癌、リンパ腫）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・抗体薬物複合体市場の概要 ・世界の主要地域別抗体薬物複合体市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の抗体薬物複合体市場規模2015-2026：種類別（アドセトリス（Adcetris）、カドサイラ（Kadcyla）） ・世界の抗体薬物複合体市場規模2015-2026：用途別（乳癌、リンパ腫） ・抗体薬物複合体の北米市場規模2015-2020 ・抗体薬物複合体のヨーロッパ市場規模2015-2020 ・抗体薬物複合体の中国市場規模2015-2020 ・抗体薬物複合体の日本市場規模2015-2020 ・抗体薬物複合体の東南アジア市場規模2015-2020 ・抗体薬物複合体のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （ImmunoGen、Seattle Genetics、Roche、Takeda） ・抗体薬物複合体の製造コスト分析 ・販売チャネル、流通業者、顧客 ・抗体薬物複合体の市場動向・機会・課題 ・調査の結論 |
Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.
North America ranks the top in terms of global market size of Antibody Drug Conjugate, it consists of 59.12% of the international market in 2016. Europe comes the second, with 27.70% of the global market. Asia Pacific consists of 6.54%of the Antibody Drug Conjugate market in the same year.
Market Analysis and Insights: Global Antibody-drug Conjugates Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Antibody-drug Conjugates market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Antibody-drug Conjugates industry.
Based on our recent survey, we have several different scenarios about the Antibody-drug Conjugates YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 2646.2 million in 2019. The market size of Antibody-drug Conjugates will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Antibody-drug Conjugates Scope and Market Size
The global Antibody-drug Conjugates market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antibody-drug Conjugates market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antibody-drug Conjugates market is segmented into
Adcetris
Kadcyla
Segment by Application, the Antibody-drug Conjugates market is segmented into
Breast Cancer
Lymphoma
The Antibody-drug Conjugates market is analysed and market size information is provided by regions (countries). Segment by Application, the Antibody-drug Conjugates market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antibody-drug Conjugates Market Share Analysis
Antibody-drug Conjugates market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antibody-drug Conjugates business, the date to enter into the Antibody-drug Conjugates market, Antibody-drug Conjugates product introduction, recent developments, etc.
The major vendors covered:
ImmunoGen
Seattle Genetics
Roche
Takeda
…
1 Antibody-drug Conjugates Market Overview
1.1 Antibody-drug Conjugates Product Scope
1.2 Antibody-drug Conjugates Segment by Type
1.2.1 Global Antibody-drug Conjugates Sales by Type (2020-2026)
1.2.2 Adcetris
1.2.3 Kadcyla
1.3 Antibody-drug Conjugates Segment by Application
1.3.1 Global Antibody-drug Conjugates Sales Comparison by Application (2020-2026)
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Antibody-drug Conjugates Market Estimates and Forecasts (2015-2026)
1.4.1 Global Antibody-drug Conjugates Sales Growth Rate (2015-2026)
1.4.2 Global Antibody-drug Conjugates Revenue and Growth Rate (2015-2026)
1.4.3 Global Antibody-drug Conjugates Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Antibody-drug Conjugates Industry Impact
1.5.1 How the Covid-19 is Affecting the Antibody-drug Conjugates Industry
1.5.1.1 Antibody-drug Conjugates Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Antibody-drug Conjugates Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Antibody-drug Conjugates Players to Combat Covid-19 Impact
2 Antibody-drug Conjugates Estimate and Forecast by Region
2.1 Global Antibody-drug Conjugates Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Antibody-drug Conjugates Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Antibody-drug Conjugates Sales Market Share by Region (2015-2020)
2.2.2 Global Antibody-drug Conjugates Revenue Market Share by Region (2015-2020)
2.3 Global Antibody-drug Conjugates Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Antibody-drug Conjugates Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Antibody-drug Conjugates Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Antibody-drug Conjugates Estimates and Projections (2015-2026)
2.4.2 Europe Antibody-drug Conjugates Estimates and Projections (2015-2026)
2.4.3 China Antibody-drug Conjugates Estimates and Projections (2015-2026)
2.4.4 Japan Antibody-drug Conjugates Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Antibody-drug Conjugates Estimates and Projections (2015-2026)
2.4.6 India Antibody-drug Conjugates Estimates and Projections (2015-2026)
3 Global Antibody-drug Conjugates Competition Landscape by Players
3.1 Global Top Antibody-drug Conjugates Players by Sales (2015-2020)
3.2 Global Top Antibody-drug Conjugates Players by Revenue (2015-2020)
3.3 Global Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody-drug Conjugates as of 2019)
3.4 Global Antibody-drug Conjugates Average Price by Company (2015-2020)
3.5 Manufacturers Antibody-drug Conjugates Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Antibody-drug Conjugates Players (Opinion Leaders)
4 Global Antibody-drug Conjugates Market Size by Type
4.1 Global Antibody-drug Conjugates Historic Market Review by Type (2015-2020)
4.1.1 Global Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
4.1.2 Global Antibody-drug Conjugates Revenue Market Share by Type (2015-2020)
4.1.3 Global Antibody-drug Conjugates Price by Type (2014-2020)
4.2 Global Antibody-drug Conjugates Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Antibody-drug Conjugates Sales Forecast by Type (2021-2026)
4.2.2 Global Antibody-drug Conjugates Revenue Forecast by Type (2021-2026)
4.2.3 Global Antibody-drug Conjugates Price Forecast by Type (2021-2026)
5 Global Antibody-drug Conjugates Market Size by Application
5.1 Global Antibody-drug Conjugates Historic Market Review by Application (2015-2020)
5.1.1 Global Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
5.1.2 Global Antibody-drug Conjugates Revenue Market Share by Application (2015-2020)
5.1.3 Global Antibody-drug Conjugates Price by Application (2015-2020)
5.2 Global Antibody-drug Conjugates Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Antibody-drug Conjugates Sales Forecast by Application (2021-2026)
5.2.2 Global Antibody-drug Conjugates Revenue Forecast by Application (2021-2026)
5.2.3 Global Antibody-drug Conjugates Price Forecast by Application (2021-2026)
3 North America Antibody-drug Conjugates Market Facts & Figures
3.2 North America Antibody-drug Conjugates Sales Market Share by Company (2015-2020)
3.3 North America Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
3.4 North America Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
4 Europe Antibody-drug Conjugates Market Facts & Figures
4.2 Europe Antibody-drug Conjugates Sales Market Share by Company (2015-2020)
4.3 Europe Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
4.4 Europe Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
5 China Antibody-drug Conjugates Market Facts & Figures
5.2 China Antibody-drug Conjugates Sales Market Share by Company (2015-2020)
5.3 China Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
5.4 China Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
6 Japan Antibody-drug Conjugates Market Facts & Figures
6.2 Japan Antibody-drug Conjugates Sales Market Share by Company (2015-2020)
6.3 Japan Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
6.4 Japan Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
7 Southeast Asia Antibody-drug Conjugates Market Facts & Figures
7.2 Southeast Asia Antibody-drug Conjugates Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
8 India Antibody-drug Conjugates Market Facts & Figures
8.2 India Antibody-drug Conjugates Sales Market Share by Company (2015-2020)
8.3 India Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
8.4 India Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Antibody-drug Conjugates Business
12.1 ImmunoGen
12.1.1 ImmunoGen Antibody-drug Conjugates Corporation Information
12.1.2 ImmunoGen Antibody-drug Conjugates Business Overview and Total Revenue
12.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue and Gross Margin (2015-2020)
12.1.4 ImmunoGen Antibody-drug Conjugates Products Offered
12.1.5 ImmunoGen Recent Development
12.2 Seattle Genetics
12.2.1 Seattle Genetics Antibody-drug Conjugates Corporation Information
12.2.2 Seattle Genetics Antibody-drug Conjugates Business Overview and Total Revenue
12.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Seattle Genetics Antibody-drug Conjugates Products Offered
12.2.5 Seattle Genetics Recent Development
12.3 Roche
12.3.1 Roche Antibody-drug Conjugates Corporation Information
12.3.2 Roche Antibody-drug Conjugates Business Overview and Total Revenue
12.3.3 Roche Antibody-drug Conjugates Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Roche Antibody-drug Conjugates Products Offered
12.3.5 Roche Recent Development
12.4 Takeda
12.4.1 Takeda Antibody-drug Conjugates Corporation Information
12.4.2 Takeda Antibody-drug Conjugates Business Overview and Total Revenue
12.4.3 Takeda Antibody-drug Conjugates Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Takeda Antibody-drug Conjugates Products Offered
12.4.5 Takeda Recent Development
…
13 Antibody-drug Conjugates Manufacturing Cost Analysis
13.1 Antibody-drug Conjugates Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Antibody-drug Conjugates
13.4 Antibody-drug Conjugates Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Antibody-drug Conjugates Distributors List
14.3 Antibody-drug Conjugates Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Antibody-drug Conjugates Sales (Kg) Growth Rate by Type (2020-2026)
Table 2. Global Antibody-drug Conjugates Sales (Kg) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Antibody-drug Conjugates Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Antibody-drug Conjugates Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Antibody-drug Conjugates Players to Combat Covid-19 Impact
Table 8. Global Market Antibody-drug Conjugates Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Antibody-drug Conjugates Sales (Kg) by Region (2015-2020)
Table 10. Global Antibody-drug Conjugates Sales Market Share by Region (2015-2020)
Table 11. Global Antibody-drug Conjugates Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Antibody-drug Conjugates Revenue Share by Region (2015-2020)
Table 13. Global Antibody-drug Conjugates Sales (Kg) Forecast by Region (2021-2026)
Table 14. Global Antibody-drug Conjugates Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Antibody-drug Conjugates Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Antibody-drug Conjugates Revenue Share Forecast by Region (2021-2026)
Table 17. Global Antibody-drug Conjugates (Kg) of Key Companies (2015-2020)
Table 18. Global Antibody-drug Conjugates Sales Share by Company (2015-2020)
Table 19. Global Antibody-drug Conjugates Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Antibody-drug Conjugates Revenue Share by Company (2015-2020)
Table 21. Global Antibody-drug Conjugates by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody-drug Conjugates as of 2019)
Table 22. Global Antibody-drug Conjugates Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Antibody-drug Conjugates Manufacturing Sites and Area Served
Table 24. Manufacturers Antibody-drug Conjugates Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Antibody-drug Conjugates Players
Table 27. Global Antibody-drug Conjugates Sales (Kg) by Type (2015-2020)
Table 28. Global Antibody-drug Conjugates Sales Share by Type (2015-2020)
Table 29. Global Antibody-drug Conjugates Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Antibody-drug Conjugates Price (Kg) by Type (2015-2020)
Table 31. Global Antibody-drug Conjugates Sales Share by Type (2021-2026)
Table 32. Global Antibody-drug Conjugates Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Antibody-drug Conjugates Revenue Share by Type (2021-2026)
Table 34. Global Antibody-drug Conjugates Price (Kg) by Type (2021-2026)
Table 35. Global Antibody-drug Conjugates Sales (Kg) by Application (2015-2020)
Table 36. Global Antibody-drug Conjugates Sales Share by Application (2015-2020)
Table 37. Global Antibody-drug Conjugates Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Antibody-drug Conjugates Price (Kg) by Application (2015-2020)
Table 39. Global Antibody-drug Conjugates Sales (Kg) by Application (2021-2026)
Table 40. Global Antibody-drug Conjugates Sales Share by Application (2021-2026)
Table 41. Global Antibody-drug Conjugates Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Antibody-drug Conjugates Revenue Share by Application (2021-2026)
Table 43. Global Antibody-drug Conjugates Price (Kg) by Application (2021-2026)
Table 44. United States Antibody-drug Conjugates Sales (Kg) by Company (2015-2020)
Table 45. United States Antibody-drug Conjugates Sales Market Share by Company (2015-2020)
Table 46. United States Antibody-drug Conjugates Sales (Kg) by Type (2015-2020)
Table 47. United States Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
Table 48. United States Antibody-drug Conjugates Sales (Kg) by Application (2015-2020)
Table 49. United States Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
Table 50. Europe Antibody-drug Conjugates Sales (Kg) by Company (2015-2020)
Table 51. Europe Antibody-drug Conjugates Sales Market Share by Company (2015-2020)
Table 52. Europe Antibody-drug Conjugates Sales (Kg) by Type (2015-2020)
Table 53. Europe Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
Table 54. Europe Antibody-drug Conjugates Sales (Kg) by Application (2015-2020)
Table 55. Europe Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
Table 56. China Antibody-drug Conjugates Sales (Kg) by Company (2015-2020)
Table 57. China Antibody-drug Conjugates Sales Market Share by Company (2015-2020)
Table 58. China Antibody-drug Conjugates Sales (Kg) by Type (2015-2020)
Table 59. China Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
Table 60. China Antibody-drug Conjugates Sales (Kg) by Application (2015-2020)
Table 61. China Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
Table 62. Japan Antibody-drug Conjugates Sales (Kg) by Company (2015-2020)
Table 63. Japan Antibody-drug Conjugates Sales Market Share by Company (2015-2020)
Table 64. Japan Antibody-drug Conjugates Sales (Kg) by Type (2015-2020)
Table 65. Japan Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
Table 66. Japan Antibody-drug Conjugates Sales (Kg) by Application (2015-2020)
Table 67. Japan Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Antibody-drug Conjugates Sales (Kg) by Company (2015-2020)
Table 69. Southeast Asia Antibody-drug Conjugates Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Antibody-drug Conjugates Sales (Kg) by Type (2015-2020)
Table 71. Southeast Asia Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Antibody-drug Conjugates Sales (Kg) by Type (2015-2020)
Table 73. Southeast Asia Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
Table 74. India Antibody-drug Conjugates Sales (Kg) by Company (2015-2020)
Table 75. India Antibody-drug Conjugates Sales Market Share by Company (2015-2020)
Table 76. India Antibody-drug Conjugates Sales (Kg) by Type (2015-2020)
Table 77. India Antibody-drug Conjugates Sales Market Share by Type (2015-2020)
Table 78. India Antibody-drug Conjugates Sales (Kg) by Application (2015-2020)
Table 79. India Antibody-drug Conjugates Sales Market Share by Application (2015-2020)
Table 80. ImmunoGen Corporation Information
Table 81. ImmunoGen Description and Business Overview
Table 82. ImmunoGen Antibody-drug Conjugates Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. ImmunoGen Antibody-drug Conjugates Product
Table 84. ImmunoGen Recent Development
Table 85. Seattle Genetics Corporation Information
Table 86. Seattle Genetics Description and Business Overview
Table 87. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Seattle Genetics Antibody-drug Conjugates Product
Table 89. Seattle Genetics Recent Development
Table 90. Roche Corporation Information
Table 91. Roche Description and Business Overview
Table 92. Roche Antibody-drug Conjugates Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Roche Antibody-drug Conjugates Product
Table 94. Roche Recent Development
Table . Takeda Corporation Information
Table . Takeda Description and Business Overview
Table . Takeda Antibody-drug Conjugates Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . Takeda Antibody-drug Conjugates Product
Table . Takeda Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. Antibody-drug Conjugates Distributors List
Table 103. Antibody-drug Conjugates Customers List
Table 104. Market Key Trends
Table 105. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 106. Key Challenges
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Antibody-drug Conjugates Product Picture
Figure 2. Global Antibody-drug Conjugates Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Antibody-drug Conjugates Market Share by Application in 2020 & 2026
Figure 6. Breast Cancer Examples
Figure 7. Lymphoma Examples
Figure 8. Global Antibody-drug Conjugates Sales (Kg) Growth Rate (2015-2026)
Figure 9. Global Antibody-drug Conjugates Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Antibody-drug Conjugates Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 11. Global Antibody-drug Conjugates Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Antibody-drug Conjugates Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Antibody-drug Conjugates Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Antibody-drug Conjugates Sales (Kg) Growth Rate (2015-2026)
Figure 15. Europe Antibody-drug Conjugates Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Antibody-drug Conjugates Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Antibody-drug Conjugates Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Antibody-drug Conjugates Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Antibody-drug Conjugates Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Antibody-drug Conjugates Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Antibody-drug Conjugates Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Antibody-drug Conjugates Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Antibody-drug Conjugates Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Antibody-drug Conjugates Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Antibody-drug Conjugates Players Market Share by Revenue in Antibody-drug Conjugates 2015 & 2019
Figure 26. Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Antibody-drug Conjugates Revenue Share by Type (2015-2020)
Figure 28. Global Antibody-drug Conjugates Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Antibody-drug Conjugates Revenue Share by Application (2015-2020)
Figure 30. Global Antibody-drug Conjugates Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Antibody-drug Conjugates Sales Market Share by Type in 2019
Figure 32. United States Antibody-drug Conjugates Sales Market Share by Type in 2019
Figure 33. Europe Antibody-drug Conjugates Sales Market Share by Company in 2019
Figure 34. Europe Antibody-drug Conjugates Sales Market Share by Type in 2019
Figure 35. Europe Antibody-drug Conjugates Sales Market Share by Application in 2019
Figure 36. China Antibody-drug Conjugates Sales Market Share by Company in 2019
Figure 37. China Antibody-drug Conjugates Sales Market Share by Type in 2019
Figure 38. China Antibody-drug Conjugates Sales Market Share by Application in 2019
Figure 39. Japan Antibody-drug Conjugates Sales Market Share by Company in 2019
Figure 40. Japan Antibody-drug Conjugates Sales Market Share by Type in 2019
Figure 41. Japan Antibody-drug Conjugates Sales Market Share by Application in 2019
Figure 42. Southeast Asia Antibody-drug Conjugates Sales Market Share by Company in 2019
Figure 43. Southeast Asia Antibody-drug Conjugates Sales Market Share by Type in 2019
Figure 44. Southeast Asia Antibody-drug Conjugates Sales Market Share by Application in 2019
Figure 45. India Antibody-drug Conjugates Sales Market Share by Company in 2019
Figure 46. India Antibody-drug Conjugates Sales Market Share by Type in 2019
Figure 47. India Antibody-drug Conjugates Sales Market Share by Application in 2019
Figure 48. ImmunoGen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Seattle Genetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Key Raw Materials Price Trend
Figure 53. Manufacturing Cost Structure of Antibody-drug Conjugates
Figure 54. Manufacturing Process Analysis of Antibody-drug Conjugates
Figure 55. Antibody-drug Conjugates Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Porter's Five Forces Analysis
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
癌抗体薬物コンジュゲートの世界市場レポート2020 Market Analysis and Insights: Global Cancer Antibody Drug Conjugates Market The global Cancer Antibody Drug Conjugates market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Cancer Antibody Drug Conjugates Scope…- キメラ抗体の世界市場レポート2020 Market Analysis and Insights: Global Chimeric Antibody Market The global Chimeric Antibody market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Chimeric Antibody Scope and Market Size The global Chimeric Antib…
- HER2抗体の世界市場レポート2020 Market Analysis and Insights: Global HER2 Antibody Market The global HER2 Antibody market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global HER2 Antibody Scope and Market Size The global HER2 Antibody market is se…
- キメラ抗体の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Chimeric Antibody market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chimeric Antibody market re…
- モノクローナル抗体診断試薬の世界市場レポート2020 A recently published report by QY Research titled Global Monoclonal Antibody Diagnostic Reagents Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistica…